openPR Logo
Press release

Author's Tranquility Press Presents: AMIAS by Thomas Penn Johnson

10-15-2024 11:10 PM CET | Associations & Organizations

Press release from: ABNewswire

Author's Tranquility Press Presents: AMIAS by Thomas Penn

Experience the Awakening of a Great Mind Through the Lens of Love and Justice
In AMIAS [https://www.amazon.com/AMIAS-Thomas-Penn-Johnson-ebook/dp/B0CZQ21GLY/ref=monarch_sidesheet_image], Thomas Penn Johnson invites readers to step into the vibrant world of 1594 London, where the life of the renowned philosopher, writer, and political leader Francis Bacon is brought to life through the eyes of a young man on a profound journey. This captivating play captures the essence of personal discovery and the historical imagination that shaped one of history's most influential figures.

The story follows Amias, a passionate and determined character who embarks on a quest to reconnect with his long-lost lover, Francis Bacon. Amias seeks legal assistance for his employer, the exiled Portuguese Prince Don Antonio, who is in dire need of help. As Amias navigates the intricacies of the legal and political landscape, he finds himself entangled with the ambitious machinations of powerful figures who threaten their pursuit of justice.

While AMIAS is not a historical account, it skillfully weaves fact and fiction, offering readers a lifelike portrayal of Bacon's personal and social life. Through this exploration, Johnson reveals the struggles and triumphs faced by individuals in a tumultuous time, shedding light on the human experience that often lies concealed in the annals of history.

At its core, AMIAS delves into timeless themes of courage and love-forces that have inspired countless hearts throughout the ages. As Amias grapples with his own identity and desires, he discovers the strength that lies within, igniting a spark of bravery that resonates with readers today.

Join Amias on his poignant journey of self-discovery, love, and justice, and experience the enduring legacy of Francis Bacon and the era that shaped his extraordinary life.

About the Author

Thomas Penn Johnson is a gifted playwright and storyteller who draws inspiration from history to create rich narratives that captivate the imagination. Through AMIAS, he invites readers to reflect on the powerful themes of courage, love, and the quest for justice, encouraging us to connect with our own historical imaginations.

Available now on Amazon: AMIAS [https://www.amazon.com/AMIAS-Thomas-Penn-Johnson-ebook/dp/B0CZQ21GLY/ref=monarch_sidesheet_image] by Thomas Penn Johnson.

For media inquiries, please contact Author's Tranquility Press at http://www.authorstranquilitypress.com.

About Author's Tranquility Press

Author's Tranquility Press is a top publicity agency known for delivering innovative solutions designed to help writers across genres to reach a wider audience. The company combines the use of the latest technologies and the expertise and diverse experience of the team to provide quality, relatable content to as many people as possible, irrespective of their location across the globe.

Media Contact
Company Name: Author's Tranquility Press
Contact Person: Louela Sanders - Marketing Fulfillment Associate
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=authors-tranquility-press-presents-amias-by-thomas-penn-johnson]
Phone: 8664118655
Address:3900 N Commerce Dr. Suite 300 #1255
City: Atlanta
State: GA, 30344
Country: United States
Website: http://www.authorstranquilitypress.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Author's Tranquility Press Presents: AMIAS by Thomas Penn Johnson here

News-ID: 3694594 • Views:

More Releases from ABNewswire

Exploring the Impact of U.S. Government Shutdown on the Global Markets - An Exclusive Report by Enhanced Investment Management Limited
Exploring the Impact of U.S. Government Shutdown on the Global Markets - An Excl …
Image: https://www.abnewswire.com/upload/2025/11/6ab92174e3dc0ee6c1bfafc8e655cfb4.jpg A shutdown of the U.S. federal government, when Congress fails to pass spending legislation and many agencies cease non-essential operations, poses a material risk to the economy. But when viewed through the lens of market history and global asset flows, the evidence suggests that such shutdowns are often absorbed by the markets and, in several ways, may present tactical opportunities for globally diversified investors. 1. What a U.S. Government Shutdown
Green Ammonia Market size growing at CAGR of 82.47% by 2030 | Rising Fertilizer Needs, Maritime Fuel Demand, Says Mordor Intelligence
Green Ammonia Market size growing at CAGR of 82.47% by 2030 | Rising Fertilizer …
The latest research by Mordor Intelligence covers the "Green Ammonia Market," delivering insights into market dynamics, drivers of growth, and long-term forecasts. Green Ammonia Market Overview: The global green ammonia market is expanding steadily as countries accelerate the shift toward low-carbon fertilizer, marine fuel, power generation, and hydrogen transport solutions. The green ammonia market [https://www.mordorintelligence.com/industry-reports/green-ammonia-market?utm_source=abnewswire] size is expected to grow from 0.27 million tons in 2025 to 5.41 million tons by 2030,
Point of Care Diagnostics Market to Reach USD 84.93 Billion by 2030, Driven by Rising Demand for Near-Patient Testing
Point of Care Diagnostics Market to Reach USD 84.93 Billion by 2030, Driven by R …
Mordor Intelligence has published a new report on Point Of Care Diagnostics Market offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction The Point Of Care Diagnostics Market [https://www.mordorintelligence.com/industry-reports/point-of-care-diagnostics?utm_source=abnewswire] size is estimated at USD 53.63 billion in 2025, and is expected to reach USD 84.93 billion by 2030, at a CAGR of 9.63% during the forecast period (2025-2030). The market's growth is fueled by the increasing need for rapid,
Enteral Feeding Devices Market Forecast to Reach USD 4.94 Billion by 2030, Driven by Safety Standards, Home Care, and ENFit Adoption
Enteral Feeding Devices Market Forecast to Reach USD 4.94 Billion by 2030, Drive …
Mordor Intelligence has published a new report on enteral feeding devices market offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction The enteral feeding devices market [https://www.mordorintelligence.com/industry-reports/enteral-feeding-devices-market?utm_source=abnewswire] is projected to grow from approximately USD 3.72 billion in 2025 to USD 4.94 billion by 2030, according to a recent report by Mordor Intelligence. The growth reflects a compound annual growth rate (CAGR) of around 5.84 percent, driven primarily by technological

All 5 Releases


More Releases for AMIAS

Global Candesartan Cilexetil (CAS 145040-37-5) Market 2016 - Takeda Pharmaceutic …
Candesartan (rINN) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. The prodrug candesartan cilexetil is marketed by AstraZeneca and Takeda Pharmaceuticals, commonly under the trade names Blopress, Atacand, Amias, and Ratacand. It is available in generic form. Candesartan is marketed as the cyclohexyl 1-hydroxyethyl carbonate (cilexetil) ester, known as candesartan cilexetil. Candesartan cilexetil is metabolised completely by esterases in the intestinal wall during absorption to
Global Candesartan Cilexetil (CAS 145040-37-5) Market Outlook 2016-2021
Candesartan (rINN) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. The prodrug candesartan cilexetil is marketed by AstraZeneca and Takeda Pharmaceuticals, commonly under the trade names Blopress, Atacand, Amias, and Ratacand. It is available in generic form. Candesartan is marketed as the cyclohexyl 1-hydroxyethyl carbonate (cilexetil) ester, known as candesartan cilexetil. Candesartan cilexetil is metabolised completely by esterases in the intestinal wall during absorption to